CN109045123A - A kind of composition for preventing and treating Raynaud's disease - Google Patents
A kind of composition for preventing and treating Raynaud's disease Download PDFInfo
- Publication number
- CN109045123A CN109045123A CN201811110944.9A CN201811110944A CN109045123A CN 109045123 A CN109045123 A CN 109045123A CN 201811110944 A CN201811110944 A CN 201811110944A CN 109045123 A CN109045123 A CN 109045123A
- Authority
- CN
- China
- Prior art keywords
- parts
- disease
- radix
- composition
- raynaud
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of compositions for preventing and treating Raynaud's disease, it is characterised in that is made of raw material from the following weight: 5~12 4~10 parts of Fen, Aralia wood of Radix Astragali, 3~8 parts of Radix Salviae Miltiorrhizae, 3~8 parts of radix cynanchi bungei, 2~5 parts of radix paeoniae rubra, 2~5 parts of monkshood, 2~5 parts of cortex cinnamomi, 3~8 parts of asarum.The present invention has preferable invigorating qi for strengthening superficies, treats Raynaud's disease.
Description
Technical field
The present invention relates to Traditional Chinese medicine health-preserving fields, and in particular to a kind of composition for preventing and treating Raynaud's disease.
Background technique
Currently, Chinese GDP per capita alreadys exceed 4000 dollars, and fast forwards through to higher level.In people
Clothing, food, lodging and transportion -- basic necessities of life etc. demand obtain satisfaction after, the problem of spirit and health aspect will necessarily be focused more on.Current society
Meeting, with the acceleration of people's life rhythm, living environment constantly change, and subhealth group increasingly increases, the health problem of the public
Also more and more prominent.Tcm health preserving has a long history precipitating in China.Tcm health preserving focuses on globality and systematicness, purpose
It is prevention disease, preventives treatment of disease.The famous representative works of theory of traditional Chinese medical science are Huangdi's Internal Classics.It is guidance with Traditional Chinese medical theory, abides by
The changing rule for following yin-yang and five elements biochemistry collection carries out scientific maintenance to human body, keeps life and health vigor.
Raynaud's disease be it is a kind of to the cold or it is nervous after, cause acro-ischemia to change with paroxysmal acra parteriole strong contraction
Become the disease of feature, also known as acra vasospastic disease.When breaking-out, acra skin becomes livid purple from pale, then switchs to flush.
The cause of disease of Raynaud's disease is still not exclusively clear at present, related to heredity and environmental factor.It is cold stimulation, excited or nervous
It is main excitation condition.Other inducements have infection, fatigue etc..Raynaud's disease can be such that thin vessels occlude, and cause digit ischemic downright bad.
Serious person may occur in which refer to end finger pulp flatten, gangrene, phalangette can due to ischemic necrosis, be absorbed, dissolve, occur shortening or
It cuts and refers to phenomenon.In some patients having a low resistance, digit ischemic and ulcer occurs and is likely to result in the diseases such as osteomyelitis, septicemia
Disease, therefore, pole need to develop Chinese medicine to prevent and treat Raynaud's disease.
Summary of the invention
It is an object of the invention to overcome disadvantage existing in the prior art, a kind of composition for preventing and treating Raynaud's disease is provided.
The composition of a kind of prevention and treatment Raynaud's disease, it is characterised in that be made of raw material from the following weight: Radix Astragali 5~
It is 12 4~10 parts of Fen, Aralia woods, 3~8 parts of Radix Salviae Miltiorrhizae, 3~8 parts of radix cynanchi bungei, 2~5 parts of radix paeoniae rubra, 2~5 parts of monkshood, 2~5 parts of cortex cinnamomi, thin
Pungent 3~8 parts.
A kind of composition of above-mentioned prevention and treatment Raynaud's disease the preparation method comprises the following steps:
(1) above-mentioned raw materials are weighed by the parts by weight: featured, cleaning, sunning, drying to moisture content≤3%；
(2) micropowders of each component are obtained through pulverizing respectively；
(3) uniformly by each component micropowders mixture, stir evenly, granulation to get.
As a preferred solution of the present invention, it is characterised in that be made of raw material from the following weight: 9 Fen, Aralia of Radix Astragali
Wooden 9 parts, 7 parts of Radix Salviae Miltiorrhizae, 4 parts of radix cynanchi bungei, 4 parts of radix paeoniae rubra, 2 parts of monkshood, 5 parts of cortex cinnamomi, 3 parts of asarum.
A kind of raw material effect parsing of above-mentioned composition for preventing and treating Raynaud's disease:
Radix Astragali: invigorating qi for strengthening superficies, diuresis, pus draining and toxin expelling, myogenic enhance hematopoiesis function;Improve myocardial function；
Aralia wood: wind-damp dispelling, diuresis, scattered blood stasis, detumescence poison；
Radix Salviae Miltiorrhizae: stasis-dispelling and pain-killing, promoting blood circulation dysmenorrhea, relieving restlessness and restlessness；
Radix cynanchi bungei: nourishing liver and kidney, strengthening the bones and muscles, benefiting essence-blood, reinforcing spleen to promote digestion, detoxification sore treatment；
Radix paeoniae rubra: clearing heat and cooling blood, removing blood stasis and acesodyne, antithrombotic, platelet aggregation-against, reducing blood lipid；
Monkshood: recuperating depleted yang, mends fire supporing yang, eliminating cold to stop pain；
Cortex cinnamomi: mends fire supporing yang, guiding fire to origin, eliminating cold to stop pain, warming meridian；
Asarum: wind-dispelling, cold dispelling, sensible analgesic, warm lung eliminating the phlegm.
The utility model has the advantages that
1, invigorating qi for strengthening superficies；
2, Raynaud's disease is treated.
Specific embodiment:
Embodiment one:
A kind of composition of prevention and treatment Raynaud's disease, it is characterised in that be made of raw material from the following weight: 9 Fen, Aralia of Radix Astragali
Wooden 9 parts, 7 parts of Radix Salviae Miltiorrhizae, 4 parts of radix cynanchi bungei, 4 parts of radix paeoniae rubra, 2 parts of monkshood, 5 parts of cortex cinnamomi, 3 parts of asarum.
Embodiment two:
A kind of composition of prevention and treatment Raynaud's disease, it is characterised in that be made of raw material from the following weight: 10 Fen, Aralia of Radix Astragali
Wooden 8 parts, 6 parts of Radix Salviae Miltiorrhizae, 5 parts of radix cynanchi bungei, 3 parts of radix paeoniae rubra, 3 parts of monkshood, 4 parts of cortex cinnamomi, 4 parts of asarum.
Embodiment three:
A kind of composition of prevention and treatment Raynaud's disease, it is characterised in that be made of raw material from the following weight: 11 Fen, Aralia of Radix Astragali
Wooden 7 parts, 5 parts of Radix Salviae Miltiorrhizae, 6 parts of radix cynanchi bungei, 2 parts of radix paeoniae rubra, 4 parts of monkshood, 3 parts of cortex cinnamomi, 5 parts of asarum.
A kind of composition of above-mentioned prevention and treatment Raynaud's disease the preparation method comprises the following steps:
(1) above-mentioned raw materials are weighed by the parts by weight: featured, cleaning, sunning, drying to moisture content≤3%；
(2) micropowders of each component are obtained through pulverizing respectively；
(3) uniformly by each component micropowders mixture, stir evenly, granulation to get.
Experiment effect of the invention
Reynolds disease symptoms crowd 100 are taken, each taking 2 ~ 5g of the present composition, 2 times a day.And record using effect.
Efficacy evaluation:
1, fully recover: pathological symptom completely disappears, functional rehabilitation, without other lesions.
2, effective: the big portion of pathological symptom disappears, and function is restored substantially, without other lesions.
3, effectively: pathological symptom is substantially reduced, and function is restored, without other lesions.
4, invalid: pathological symptom improvement is unobvious, or has other syndromes.
The data of crowd are as follows: after record 30 days
| Symptom number | Recovery from illness | It is effective | Effectively | In vain |
| 100 | 92 | 3 | 3 | 2 |
The present invention has good control efficiency to Raynaud's disease as can be seen from the above table.
The above described is only a preferred embodiment of the present invention, being not that the invention has other forms of limitations, appoint
What those skilled in the art changed or be modified as possibly also with the technology contents of the disclosure above equivalent variations etc.
Imitate embodiment.But without departing from the technical solutions of the present invention, according to the technical essence of the invention to embodiment institute on
Any simple modification, equivalent variations and the remodeling made, still fall within the protection scope of technical solution of the present invention.
Claims (2)
1. a kind of composition for preventing and treating Raynaud's disease, it is characterised in that be made of raw material from the following weight: 5~12 Fen, Aralia of Radix Astragali
Wooden 4~10 parts, 3~8 parts of Radix Salviae Miltiorrhizae, 3~8 parts of radix cynanchi bungei, 2~5 parts of radix paeoniae rubra, 2~5 parts of monkshood, 2~5 parts of cortex cinnamomi, asarum 3~8
Part.
2. a kind of according to claim 1, composition for preventing and treating Raynaud's disease, it is characterised in that composition can be powdery, soup
Agent, particle, pellet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811110944.9A CN109045123A (en) | 2018-09-22 | 2018-09-22 | A kind of composition for preventing and treating Raynaud's disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811110944.9A CN109045123A (en) | 2018-09-22 | 2018-09-22 | A kind of composition for preventing and treating Raynaud's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109045123A true CN109045123A (en) | 2018-12-21 |
Family
ID=64763463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811110944.9A Pending CN109045123A (en) | 2018-09-22 | 2018-09-22 | A kind of composition for preventing and treating Raynaud's disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109045123A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104857099A (en) * | 2015-05-24 | 2015-08-26 | 四川双鑫生物科技有限公司 | Oral medicine for treating raynaud's syndrome and preparation method of oral medicine |
| CN105288376A (en) * | 2015-12-01 | 2016-02-03 | 青岛华之草医药科技有限公司 | Method for preparing traditional Chinese medicine preparation capable of treating raynaud disease |
| CN105288377A (en) * | 2015-12-01 | 2016-02-03 | 青岛华之草医药科技有限公司 | Traditional Chinese medicine preparation for curing Raynaud disease |
-
2018
- 2018-09-22 CN CN201811110944.9A patent/CN109045123A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104857099A (en) * | 2015-05-24 | 2015-08-26 | 四川双鑫生物科技有限公司 | Oral medicine for treating raynaud's syndrome and preparation method of oral medicine |
| CN105288376A (en) * | 2015-12-01 | 2016-02-03 | 青岛华之草医药科技有限公司 | Method for preparing traditional Chinese medicine preparation capable of treating raynaud disease |
| CN105288377A (en) * | 2015-12-01 | 2016-02-03 | 青岛华之草医药科技有限公司 | Traditional Chinese medicine preparation for curing Raynaud disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109045123A (en) | A kind of composition for preventing and treating Raynaud's disease | |
| CN107362264A (en) | A kind of external application application plaster suitable for arthropathy | |
| CN103550638B (en) | Traditional Chinese medicine for treating skin itch with syndrome of superficies attacked by wind-heat | |
| CN106511671A (en) | Medicinal liquor for treating hyperostosis, rheumatism and gout disease | |
| CN109091651A (en) | A kind of preparation method preventing and treating cirrhosis | |
| CN108939016A (en) | A kind of composition for preventing and treating fibroid | |
| CN108904765A (en) | One kind preventing antapoplectic preparation method | |
| CN103099999B (en) | Traditional Chinese medicine for treating gout disease | |
| CN108938862A (en) | A kind of composition for preventing and treating hyposexuality disease | |
| CN109010604A (en) | A kind of preparation method preventing and treating hemospermia syndrome | |
| CN109010476A (en) | A kind of composition for preventing and treating intestinal obstruction | |
| CN108969702A (en) | A kind of preparation method preventing and treating balanitis | |
| CN108938913A (en) | A kind of composition for preventing and treating heart failure | |
| CN109010643A (en) | A kind of preparation method preventing and treating acute nephritis | |
| CN108904764A (en) | One kind preventing antapoplectic composition | |
| CN109010533A (en) | A kind of preparation method preventing and treating chronic renal failure | |
| CN108938876A (en) | A kind of composition for preventing and treating acute nephritis | |
| CN103611002B (en) | A kind of Chinese medicine composition for the treatment of chronic nephritis | |
| CN109091576A (en) | A kind of preparation method preventing and treating chronic nephritis | |
| CN108904670A (en) | A kind of preparation method preventing and treating hemorrhoid | |
| CN109125673A (en) | A kind of preparation method of fingered citron health care | |
| CN108969747A (en) | A kind of preparation method preventing and treating pregnancy reaction | |
| CN108904715A (en) | A kind of preparation method of anti-treating rheumatic arthritis | |
| CN109125520A (en) | A kind of composition for preventing and treating acute nephritis | |
| CN108938958A (en) | A kind of preparation method preventing and treating female climacteric syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181221 |